Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 224-957-0 | CAS number: 4573-50-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin irritation (OECD 439 and 431): irritating
Eye irritation (OECD 405): irritating
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin corrosion: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 27 June - 15 July 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- / no application of correction factor on positive control, no demonstration of technical proficiency, 3 min incubation at room temperature instead of at 37°C (OECD 431)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 431 (In Vitro Skin Corrosion: Reconstructed Human Epidermis (RHE) Test Method)
- Version / remarks:
- 29 July 2016
- Deviations:
- yes
- Remarks:
- / no application of correction factor on positive control, no demonstration of technical proficiency, 3 min incubation at room temperature instead of at 37°C (OECD 431)
- Qualifier:
- according to guideline
- Guideline:
- other: EU method B.40 BIS. (In Vitro Skin Corrosion: Human Skin Model Test)
- Version / remarks:
- 30 May 2008
- Deviations:
- yes
- Remarks:
- / no demonstration of technical proficiency
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Hess. Ministerium für Umwelt, Klimaschutz, Landwirtschaft und Verbrauchersch utz, Wiesbaden, Germany
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Source strain:
- other: EpiDermTM; reconstructed three-dimensional human epidermis (EPI-200); 00267
- Justification for test system used:
- The normal, human-derived epidermal keratinocytes (NHEK) attain levels of differentiation at the cutting edge of in vitro skin technology. Ultrastructurally, the skin models closely parallel human skin.
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: EpiDerm™ Kit (Epi-200, MatTek Corporation (Bratislava, Slovakia)
- Tissue lot number: 23345
- Delivery date: 12 June 2016
- Date of initiation of testing: 27 June 2016
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: room temperature for the 3 ± 0.5 min exposure periods, 37 ± 1.5 °C for the 60 ± 5 min exposure period
REMOVAL OF TEST MATERIAL AND CONTROLS
-Volume and number of washing steps: rinsed 20 times with DPBS
- Observable damage in the tissue due to washing: no
- Modifications to validated SOP: no
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: 1mg/mL
- Incubation time: 3 h
- Spectrophotometer: microplate reader (Versamax®, Molecular Devices, SoftMax Pro Enterprise (version 4.7.1))
- Wavelength: 570 nm
FUNCTIONAL MODEL CONDITIONS WITH REFERENCE TO HISTORICAL DATA
- Viability: OD = 1.783 ± 0.027 (Acceptance criteria: 1.0-3.0)
- Barrier function: ET-50 = 6.16 h (Acceptance criteria: 4.77 - 8.72)
- Morphology: functional stratum corneum, a viable basal cell layer and intermediate spinous and granular layers
- Contamination: no contamination
NUMBER OF REPLICATE TISSUES: duplicate
CONTROL TISSUES USED IN CASE OF MTT DIRECT INTERFERENCE
- Killed tissues
- Procedure used to prepare the killed tissues: freezing
- N. of replicates : 2
- Method of calculation used: True viability = Viability of treated tissue – Interference from test chemical = ODtvt – ODkt; ODkt = (mean ODtkt – mean ODukt)
tvt = treated viable tissue
kt = killed tissues
tkt = treated killed tissue
ukt = untreated killed tissue (NC treated tissue)
Since the interference by the test item extract is < 30% of the negative control value, the net OD of the test item extract treated killed control was subtracted from the mean OD of the test item extract treated viable tissues to obtain the true amount of MTT reduction that reflects metabolic conversion only.
NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTION: 2
PREDICTION MODEL / DECISION CRITERIA (choose relevant statement)
- The test substance is considered to be corrosive to skin if the viability after 3 minutes exposure is less than 50% (optional Sub-category 1A), or if the viability after 3 minutes exposure is greater than or equal to 50 % and the viability after 1 hour exposure is less than 15% (optional Sub-category 1B and 1C).
- The test substance is considered to be non-corrosive to skin if the viability after 3 minutes exposure is greater than or equal to 50% and the viability after 1 hour exposure is greater than or equal to 15%. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- yes, concurrent MTT non-specific colour control
- Amount/concentration applied:
- TEST MATERIAL
- Amount(s) applied: 50 µl
- Concentration: 79.4 μL/cm2
NEGATIVE CONTROL
- Amount(s) applied: 50 μL
POSITIVE CONTROL
- Amount(s) applied (volume or weight): 50 μL
- Concentration: 8 N - Duration of treatment / exposure:
- 3 ± 0.5 min and 60 ± 5 min
- Number of replicates:
- 2
- Type of coverage:
- other: in vitro system
- Preparation of test site:
- other: intact reconstructed human epidermis
- Vehicle:
- unchanged (no vehicle)
- Irritation / corrosion parameter:
- % tissue viability
- Remarks:
- of negative control
- Run / experiment:
- mean value of the test item (100%), 3 min exposure
- Value:
- 114
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Irritation / corrosion parameter:
- % tissue viability
- Remarks:
- of negative control
- Run / experiment:
- mean value of the test item (100%), 60 min exposure
- Value:
- 56.7
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- - OTHER EFFECTS:
- Visible damage on test system: no
- Direct-MTT reduction: yes
- Colour interference with MTT: no
DEMONSTRATION OF TECHNICAL PROFICIENCY: no
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: yes, as the mean OD of the tissue replicates treated with the negative control is ≥ 0.8 and ≤ 2.8 for every exposure time (values between 1.693 and 1.924)
- Acceptance criteria met for positive control: yes, as the mean viability of the tissue replicates treated with the positive control for 1 hour, is <15% compared to the negative control (7.9%)
- Acceptance criteria met for variability between replicate measurements: yes, as the Coefficient of Variation (CV) is in the range of 20 – 100% viability between tissue replicates is ≤ 30% (values between 3.8% and 16.6%) - Interpretation of results:
- other: not corrosive
- Conclusions:
- The test item PIPERITONE was non corrosive to skin according to EU CLP and UN GHS
- Executive summary:
After exposure of the tissues to the test item the relative absorbance value did not decrease (114.0%) after 3 minutes exposure. After the 1 hour exposure the viability was reduced to 56.7%. The correction factor derived from the additional test with freeze-killed tissues was considered. Both values did not affect the threshold for corrosivity which is defined to be 50% after the 3 minutes exposure and 15% after the 1 hour exposure. Therefore, the test item was not considered to be corrosive.
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 04 May - 06 June 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- 28 July 2015
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
- Version / remarks:
- Commission Regulation 440/2008, 1st ATP 2009
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Hess. Ministerium für Umwelt, Klimaschutz, Landwirtschaft und Verbraucherschutz, Wiesbaden, Germany
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Source strain:
- other: EpiDerm™; Reconstructed Human Epidermal Model (EPI-200), Strain 00267, Lot Nr 23339
- Details on animal used as source of test system:
- SOURCE ANIMAL
- Source: MatTek Corporation, Bratislava, Slovakia
The EpiDerm™ tissue consists of normal, human-derived epidermal keratinocytes which have been cultured to form a multilayered, highly differentiated model of the human epidermis. It consists of organized basal, spinous and granular layers, and a multi-layered stratum corneum containing intercellular lamellar lipid layers arranged in patterns analogous to those found in vivo. - Justification for test system used:
- Systemic reactions play a minor role in modulating local skin toxicity potential of chemicals, so skin irritation potential may be predicted by in vitro systems, provided they are sufficiently complex to mimic human skin barrier and cell reactivity.
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: 37 ± 1.5 °C
- Temperature of post-treatment incubation (if applicable): room temperature, later again 37 ± 1.5 °C
REMOVAL OF TEST MATERIAL AND CONTROLS
- Number of washing steps: at least 15
DYE BINDING METHOD
- Dye used in the dye-binding assay: MTT
- Spectrophotometer: microplate reader (Versamax® Molecular Devices, Softmax Pro, version 4.7.1)
- Wavelength: 570 nm
NUMBER OF INDEPENDENT TESTING RUNS / EXPERIMENTS TO DERIVE FINAL PREDICTION: One experiment was carried out in triplicate plating.
PREDICTION MODEL / DECISION CRITERIA
- The test substance is considered to be irritant to skin if the mean relative tissue viability of three individual tissues is reduced to ≤ 50% of the negative control.
- The test substance is considered to be non-irritant to skin if the mean relative tissue viability of three individual tissues is > 50% of the negative control. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL
- Amount(s) applied: 30 μL
- Concentration (if solution): 47 μL/cm²
NEGATIVE CONTROL
- Amount(s) applied: 30 μL
POSITIVE CONTROL
- Amount(s) applied (volume or weight): 30 μL
- Concentration (if solution): 5% SLS - Duration of treatment / exposure:
- 1 h
- Duration of post-treatment incubation (if applicable):
- 43 h
- Number of replicates:
- 3
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- mean value of test item (47 μL/cm²)
- Value:
- 4.8
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- - OTHER EFFECTS:
- Direct-MTT reduction: No. The test item did not reduce MTT (test for direct MTT reduction).
- Colour interference with MTT: No. The test item did not change colour when mixed with deionised water (test for colour interference). Also its intrinsic colour was not intensive.
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: After treatment with the negative control the absorbance values (1.525, 1.957, 1.950) were in the range of the required acceptability criterion of mean OD ≥ 0.8 and ≤ 2.8 for the 60 min treatment.
- Acceptance criteria met for positive control: Exposure to the positive control induced a decrease in the relative absorbance as compared to the negative control to 4.3% thus confirming the validity of the test system.
- Acceptance criteria met for variability between replicate measurements: yes, but value (19%) is slightly above the threshold of the OECD Guideline 439 ( < 18%) - Interpretation of results:
- other: irritating potential (Skin Irrit. 2 or Skin Corr. 1 according to Regulation (EC) No 1272/2008)
- Conclusions:
- Under the conditions of the test, the test substance was shown to have an irritating potential towards reconstructed human epidermis tissue in the EpiDerm™ model.
- Executive summary:
The skin irritation potential of the test substance was determined by an in vitro skin irritation test using a reconstructed human skin model according to OECD Guideline 439 and in compliance with GLP (2016).
After treatment with the test substance for 60 min the tissue viability decreased to 4.8% compared to the negative control (threshold for irritancy ≤ 50%). Therefore, the test substance is considered to possess an irritant potential.
Referenceopen allclose all
Table 1: MTT assay after 3 min exposure
Negative control |
Positive control |
Test item |
||||
Tissue sample |
1 |
2 |
1 |
2 |
1 |
2 |
OD570 |
1.795 |
1.775 |
0.594 |
0.647 |
2.276 |
2.062 |
1.820 |
1.717 |
0.603 |
0.685 |
2.019 |
1.944 |
|
1.850 |
1.693 |
0.619 |
0.658 |
2.002 |
1.949 |
|
OD570(mean) |
1.821 |
1.728 |
0.606 |
0.663 |
2.099 |
1.985 |
OD570(mean values* of replicates) |
1.737 |
0.597 |
2.005 |
|||
CV (%) |
3.8 |
6.8 |
4.0 |
|||
rel. viability (%) |
100.0 |
34.4 |
114.0** |
Blanc (mean) = 0.038
* after blanc correction of single values
** after data correction because of MTT interference
CV = Coefficient of Variation
Table 2: MTT assays after 60 min exposure
Negative control |
Positive control |
Test item |
||||
Tissue sample |
1 |
2 |
1 |
2 |
1 |
2 |
OD570 |
1.924 |
1.845 |
0.198 |
0.158 |
1.232 |
0.968 |
1.895 |
1.715 |
0.184 |
0.166 |
1.181 |
0.949 |
|
1.768 |
1.728 |
0.184 |
0.167 |
1.190 |
0.951 |
|
OD570(mean) |
1.862 |
1.763 |
0.189 |
0.164 |
1.201 |
0.956 |
OD570(mean values* of replicates) |
1.776 |
0.140 |
1.042 |
|||
CV (%) |
4.0 |
12.6 |
16.6 |
|||
rel. viability (%) |
100.0 |
7.9 |
56.7** |
Blanc (mean) = 0.038
* after blanc correction of single values
** after data correction because of MTT interference
CV = Coefficient of Variation
Table 2: MTT assay after 60 min exposure
Dose |
Tissue No. |
OD570 |
OD570(mean |
Mean absorbance of replicates blank corrected |
Mean absorbance of replicates after blank correction |
Rel. Absorbance [%] |
Relative Standard Deviation |
Viability (Mean Rel. Absorbance |
||
Well 1 |
Well 2 |
Well 3 |
||||||||
Blank |
0.036 |
0.037 |
0.036 |
0.036 |
||||||
Negative |
1 |
1.578 |
1.549 |
1.558 |
1.562 |
1.525 |
1.811 |
84.2 |
13.7 |
100.0 |
2 |
2.026 |
1.984 |
1.971 |
1.994 |
1.957 |
108.1 |
||||
3 |
2.024 |
1.971 |
1.965 |
1.986 |
1.950 |
107.7 |
||||
Positive |
1 |
0.098 |
0.097 |
0.097 |
0.097 |
0.061 |
0.078 |
3.4 |
19.0 |
4.3 |
2 |
0.118 |
0.121 |
0.118 |
0.119 |
0.082 |
4.6 |
||||
3 |
0.125 |
0.126 |
0.126 |
0.126 |
0.089 |
4.9 |
||||
Test |
1 |
0.135 |
0.137 |
0.133 |
0.135 |
0.098 |
0.087 |
5.4 |
11.6 |
4.8 |
2 |
0.117 |
0.116 |
0.116 |
0.116 |
0.080 |
4.4 |
||||
3 |
0.119 |
0.119 |
0.118 |
0.119 |
0.082 |
4.5 |
* = relative absorbance per tissue [rounded values]: 100 x (absorbance tissue)/(mean adsorbance negative control)
** = relative absorbance per treatment group [rounded values]: 100 x (mean absorbance test item/ positive control)/(mean adsorbance negative control)
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 26 June - 04 July 2000
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- / GLP guideline study with minor deviations (no information about animal age, body weight determined only once)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- Version / remarks:
- 02 Oct 2012
- Deviations:
- yes
- Remarks:
- / GLP guideline study with minor deviations (no information about animal age, body weight determined only once)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion)
- Version / remarks:
- 30 May 2008
- Deviations:
- yes
- Remarks:
- / GLP guideline study with minor deviations (no information about animal age, body weight determined only once)
- GLP compliance:
- yes
- Species:
- rabbit
- Strain:
- other: SPF albino rabbits, Chbb:HM(SPF) - Littlerussian
- Details on test animals or tissues and environmental conditions:
- TEST ANIMALS
- Source: BI Pharma KG, Biberach, Germany
- Weight at study initiation: 1.5 - 1.7 kg (females)
- Housing: individual in PPO cages with perforated floor
- Diet : pelleted diet Altromin 2123 (Altromin, Lage, Lippe Germany), ad libitum
- Water: water (acidified with hydrochloric acid, pH 2,5), ad libitum (analysis was performed)
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 ± 3
- Humidity (%): 55 ± 15
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12/ 12
IN-LIFE DATES: From: 26 June To: 04 July 2000 - Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent no treatment
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.1 mL of the test article were applied into one eye of the rabbits. - Duration of treatment / exposure:
- single application without washing
- Observation period (in vivo):
- 7 days
Reading time points: 1, 24, 48, 72 h and 7 days after the treatment - Number of animals or in vitro replicates:
- 4 females
- Details on study design:
- SCORING SYSTEM: Draize scoring system
TOOL USED TO ASSESS SCORE: fluorescein - Irritation parameter:
- cornea opacity score
- Remarks:
- before fluorescein application
- Basis:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- 1
- Max. score:
- 4
- Reversibility:
- fully reversible within: 7 days
- Irritation parameter:
- cornea opacity score
- Remarks:
- before fluorescein application
- Basis:
- animal #2
- Time point:
- 24/48/72 h
- Score:
- 0.7
- Max. score:
- 4
- Reversibility:
- fully reversible within: 3 days
- Irritation parameter:
- cornea opacity score
- Remarks:
- before fluorescein application
- Basis:
- animal #3
- Time point:
- 24/48/72 h
- Score:
- 1
- Max. score:
- 4
- Reversibility:
- fully reversible within: 7 days
- Irritation parameter:
- cornea opacity score
- Basis:
- animal #4
- Time point:
- 24/48/72 h
- Score:
- 1
- Max. score:
- 4
- Reversibility:
- fully reversible within: 7 days
- Irritation parameter:
- iris score
- Basis:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- 0.7
- Max. score:
- 2
- Reversibility:
- fully reversible within: 3 days
- Irritation parameter:
- iris score
- Basis:
- animal #2
- Time point:
- 24/48/72 h
- Score:
- 0.7
- Max. score:
- 2
- Reversibility:
- fully reversible within: 3 days
- Irritation parameter:
- iris score
- Basis:
- animal #3
- Time point:
- 24/48/72 h
- Score:
- 1
- Max. score:
- 2
- Reversibility:
- fully reversible within: 7 days
- Irritation parameter:
- iris score
- Basis:
- animal #4
- Time point:
- 24/48/72 h
- Score:
- 0.7
- Max. score:
- 2
- Reversibility:
- fully reversible within: 3 days
- Irritation parameter:
- conjunctivae score
- Basis:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- 1.7
- Max. score:
- 3
- Reversibility:
- fully reversible within: 7 days
- Irritation parameter:
- conjunctivae score
- Basis:
- animal #2
- Time point:
- 24/48/72 h
- Score:
- 1.3
- Max. score:
- 3
- Reversibility:
- fully reversible within: 7 days
- Irritation parameter:
- conjunctivae score
- Basis:
- animal #3
- Time point:
- 24/48/72 h
- Score:
- 2
- Max. score:
- 3
- Reversibility:
- fully reversible within: 7 days
- Irritation parameter:
- conjunctivae score
- Basis:
- animal #4
- Time point:
- 24/48/72 h
- Score:
- 1.3
- Max. score:
- 3
- Reversibility:
- fully reversible within: 7 days
- Irritation parameter:
- chemosis score
- Basis:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- 1.3
- Max. score:
- 4
- Reversibility:
- fully reversible within: 7 days
- Irritation parameter:
- chemosis score
- Basis:
- animal #2
- Time point:
- 24/48/72 h
- Score:
- 1
- Max. score:
- 4
- Reversibility:
- fully reversible within: 7 days
- Irritation parameter:
- chemosis score
- Basis:
- animal #3
- Time point:
- 24/48/72 h
- Score:
- 1.3
- Max. score:
- 4
- Reversibility:
- fully reversible within: 7 days
- Irritation parameter:
- chemosis score
- Basis:
- animal #4
- Time point:
- 24/48/72 h
- Score:
- 1
- Max. score:
- 4
- Reversibility:
- fully reversible within: 7 days
- Irritant / corrosive response data:
- Based on the readings before fluorescein application, all 4 animals showed a cornea opacity (scored with 1) after 1h , which was reversible within 72 h in 1/4 animals. All animals showed an Iris score of 1 after 1 h, which was reversible within 72h in 2/4 animals. Conjunctivae was observed in all animals after 1 h (scored with 3 in 1 animal and with 2 in the other 3 animals). After 24 h all animals showed a conjunctivae scored with 2. After 48 h or 72 h the scoring decreased to 1 (in 2 or 1 animal, respectively). The fourth animal showed a consistent scoring of 2 within the 72 h. Chemosis was observed in all animals after 1 h (scored with 2). 2/2 animals showed a decrease in scoring to 1 after 24 h, the other 2 animals after 48 h.
7 days after application of the test article all four animals were free of any signs of eye irritation. - Interpretation of results:
- Category 2 (irritating to eyes) based on GHS criteria
- Conclusions:
- CLP: Eye irrit 2, H319
- Executive summary:
The eye irritation potential of the test substance was determined by an in vivo eye irritation test according to OECD Guideline 405 and in compliance with GLP (2016).Application of the test substance to the rabbit eye resulted in a mean corneal opacity score of 1 in 3/4 animals, which was reversible within maximum 7 days. Thus, the test substance is considered to be irritant to the eye.
Reference
Table 1: Individual scores of eye irritation
Rabbit # |
Time [h] |
conjunctivae |
iris |
cornea |
cornea (after Fluorescein) |
|
redness |
chemosis (swelling) |
|||||
1 |
1 |
3 |
2 |
1 |
1 |
- |
24 |
2 |
2 |
1 |
1 |
1 |
|
48 |
2 |
1 |
1 |
1 |
1 |
|
72 |
1 |
1 |
0 |
1 |
1 |
|
mean |
1.7 |
1.3 |
0.7 |
1.0 |
1.0 |
|
2 |
1 |
2 |
2 |
1 |
1 |
- |
24 |
2 |
1 |
1 |
1 |
1 |
|
48 |
1 |
1 |
1 |
1 |
1 |
|
72 |
1 |
1 |
0 |
0 |
1 |
|
mean |
1.3 |
1.0 |
0.7 |
0.7 |
1.0 |
|
3 |
1 |
2 |
2 |
1 |
1 |
- |
24 |
2 |
2 |
1 |
1 |
1 |
|
48 |
2 |
1 |
1 |
1 |
1 |
|
72 |
2 |
1 |
1 |
1 |
0 |
|
mean |
2.0 |
1.3 |
1.0 |
1.0 |
0.7 |
|
4 |
1 |
2 |
2 |
1 |
1 |
- |
24 |
2 |
1 |
1 |
1 |
1 |
|
48 |
1 |
1 |
1 |
1 |
1 |
|
72 |
1 |
1 |
0 |
1 |
1 |
|
mean |
1.3 |
1.0 |
0.7 |
1.0 |
1.0 |
Iris: 0 - 2 numerical scores, Redness: 0 - 3 numerical scores, Chemosis and Cornea opacity score : 0 - 4 numerical scores
Only the scores from the readings after 24, 48 and 72 hours are included in the calculation of the individual mean scores.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Skin
The skin irritation potential of the test substance was determined by an in vitro skin irritation test using a reconstructed human skin model according to OECD Guideline 439 and in compliance with GLP (2016).
After treatment with the test substance for 60 min the tissue viability decreased to 4.8% compared to the negative control (threshold for irritancy ≤ 50%). Therefore, the test substance is considered to possess an irritant potential.
The skin corrosive potential of the test substance was determined by an in vitro skin irritation test using a reconstructed human skin model according to OECD Guideline 431 and in compliance with GLP.
After exposure of the tissues to the test item the relative absorbance value did not decrease (114.0%) after 3 minutes exposure. After the 1 hour exposure the viability was reduced to 56.7%. The correction factor derived from the additional test with freeze-killed tissues was considered. Both values did not affect the threshold for corrosivity which is defined to be 50% after the 3 minutes exposure and 15% after the 1 hour exposure. Therefore, the test item was not considered to be corrosive.
In conclusion, based on available studies, the test substance is considered to be irritating to the skin and therefore is classified as Skin Irrit. 2, H315 according to CLP.
Eye
The eye irritation potential of the test substance was determined by an in vivo eye irritation test according to OECD Guideline 405 and in compliance with GLP (2016). Application of the test substance to the rabbit eye resulted in a mean corneal opacity score of 1 in 3/4 animals, which was reversible within maximum 7 days. Thus, the test substance is considered to be irritant to the eye.
Justification for classification or non-classification
The available data on skin irritation meet the criteria for classification as Skin Irrit. Cat. 2 (H315) according to Regulation (EC) 1272/2008.
The available data on eye irritation meet the criteria for classification as Eye Irrit. Cat. 2 (H319) according to Regulation (EC) 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.